Asked by: Kirsten Oswald (Scottish National Party - East Renfrewshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the impact of racism on mental health among the Gypsy, Roma, and Traveller communities.
Answered by Gillian Keegan
No recent assessment has been made. We launched a public call for evidence to support the development of a new cross-Government 10 year plan for mental health, which closed on 7 July 2022. We will review the responses received to the call for evidence, including on the causes of poor mental health, as the plan is developed.
Asked by: Kirsten Oswald (Scottish National Party - East Renfrewshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the impact of poverty on mental health among the Gypsy, Roma, and Traveller communities.
Answered by Gillian Keegan
No recent assessment has been made. We launched a public call for evidence to support the development of a new cross-Government 10 year plan for mental health, which closed on 7 July 2022. We will review the responses received to the call for evidence, including on the causes of poor mental health, as the plan is developed.
Asked by: Kirsten Oswald (Scottish National Party - East Renfrewshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the mental health needs of Gypsy, Roma, and Traveller communities in the UK.
Answered by Gillian Keegan
No recent assessment has been made. We launched a public call for evidence to inform the development of a new cross-Government 10 year plan for mental health, which closed on 7 July 2022. We will review the responses received, including on the causes of poor mental health, as the plan is developed.
Asked by: Kirsten Oswald (Scottish National Party - East Renfrewshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 June 2022 to Question 8030 on Dementia: Drugs, whether the plans for dementia in England for the next 10 years referred to in that answer will deliver on the Government's manifesto commitment to double dementia research funding.
Answered by Gillian Keegan
The strategy will include ambitions for dementia research and plans to increase research funding for dementia.
Asked by: Kirsten Oswald (Scottish National Party - East Renfrewshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he plans to take steps in response to Alzheimer's Research UK's proposal for the establishment of a Dementia Medicines Taskforce.
Answered by Gillian Keegan
There have been no specific discussions with the devolved administrations. Officials have met Alzheimer’s Research UK to discuss this proposal and considered routes for accelerating access to such medicines for patients with NHS England and NHS Improvement.
The Accelerated Access Collaborative and the Department’s Commercial Medicines Directorate continually review the development of new medicines, including those for dementia. This provides early indication of such innovative treatments, engaging with the National Institute for Health and Care Excellence (NICE) and industry to identify challenges in delivering medicines to patients. The Innovative Licencing and Access Pathway accelerates patient access to medicines. The Innovative Medicines Fund supports early access to the most clinically promising treatments where further data is needed to support NICE’s recommendations for use in the NHS. These initiatives will apply to dementia drugs.
We will set out plans for dementia in England for the next 10 years later this year, including on diagnosis, risk reduction and prevention and research. The strategy will include ambitions for research to develop new disease-modifying treatments.
Asked by: Kirsten Oswald (Scottish National Party - East Renfrewshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has had discussions with the devolved Administrations on the proposal by Alzheimer's Research UK for the establishment of a Dementia Medicines Taskforce.
Answered by Gillian Keegan
There have been no specific discussions with the devolved administrations. Officials have met Alzheimer’s Research UK to discuss this proposal and considered routes for accelerating access to such medicines for patients with NHS England and NHS Improvement.
The Accelerated Access Collaborative and the Department’s Commercial Medicines Directorate continually review the development of new medicines, including those for dementia. This provides early indication of such innovative treatments, engaging with the National Institute for Health and Care Excellence (NICE) and industry to identify challenges in delivering medicines to patients. The Innovative Licencing and Access Pathway accelerates patient access to medicines. The Innovative Medicines Fund supports early access to the most clinically promising treatments where further data is needed to support NICE’s recommendations for use in the NHS. These initiatives will apply to dementia drugs.
We will set out plans for dementia in England for the next 10 years later this year, including on diagnosis, risk reduction and prevention and research. The strategy will include ambitions for research to develop new disease-modifying treatments.